Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH)
Open Access
- 21 August 2019
- journal article
- research article
- Published by Springer Nature in Experimental Hematology & Oncology
- Vol. 8 (1) , 1-7
Abstract
Large clonal populations of cells bearing PIG-A mutations are the sine qua non of PNH, but the PIG-A mutation itself is insufficient for clonal expansion. The association between PNH and aplastic anemia supports the immune escape model, but not all PNH patients demonstrate a history of aplasia; therefore, second genetic hits driving clonal expansion have been postulated. Based on the previous identification of JAK2 mutations in patients with a myeloproliferative/PNH overlap syndrome, we considered TET2 as a candidate gene in which mutations might be contributing to clonal expansion. Here we sequenced the TET2 and JAK2 genes in 19 patients with large PNH clones. We found one patient with a novel somatic nonsense mutation in TET2 in multiple hematopoietic lineages, which was detectable upon repeat testing. This patient has had severe thromboses and has relatively higher peripheral blood counts compared with the other patients—but does not have other features of a myeloproliferative neoplasm. We conclude that mutations in TET2 may contribute to clonal expansion in exceptional cases of PNH.Keywords
Funding Information
- The PNH Research and Support Foundation Award from the Aplastic Anemia & MDS International Foundation
This publication has 55 references indexed in Scilit:
- Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesisNature Genetics, 2012
- Paroxysmal nocturnal hemoglobinuria and concurrent JAK2V617F mutationBlood Cancer Journal, 2012
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid LeukemiaNew England Journal of Medicine, 2012
- Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNAScience, 2011
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid TransformationCancer Cell, 2011
- 3′UTR-truncated Hmga2 cDNA causes MPN-like hematopoiesis by conferring a clonal growth advantage at the level of HSC in miceBlood, 2011
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2Nature, 2010
- Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignanciesBlood, 2009
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1Science, 2009
- Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH)Blood, 2006